@CabreraAngel Grateful to be back at @GeorgiaTech. This is more than walking. It restores nervous system input through load-bearing, repetitive stepping and neuromodulation. That drives neuroplasticity and recovery. We need systems that restore function and prepare paralysis for what’s next.
Back @GeorgiaTech as a BME PhD walking the new neurorobotic accessibility corridor in a self-balancing exoskeleton 13 years after my SCI, back where I last walked. Real-world movement, full weight-bearing sensory input from passive care to active participation. This is progress!
A new wearable electronic device that can be inserted inside any shoe may be able to help people with balance issues. The affordable device from @GT_HongYeo's lab measures foot pressure and could improve stroke and Parkinson’s therapy. https://t.co/fjyETyoDda
As #SCIAwarenessMonth ends, we honor Josh Basile—the first RT300 home rider.
His journey shows what’s possible with FES technology and having a therapy system at home that works for you.
Read more: https://t.co/22sl2Gq09K
#SCI#SCIRecovery#RT300#FESCycle#FESBike#Xcite2
Registration for U2FP’s 20th Annual Science & Advocacy Symposium - happening February 15-17 in Washington, D.C., is officially open!
50% discounts for SCI Individuals/ family, and students. And PCAs are free (limit 1) Details on registration page.
Link: https://t.co/kGC58qASaf
Georgia Tech researchers have received a $3.2M NIH grant to study how aging affects walking and mobility. 🚶♀️
Led by Gregory Sawicki with Aaron Young and Kinsey Herrin, the project explores joint mechanics, muscle function & energy cost of movement.
🔗 https://t.co/xhjiXGSTJp
Our heroes can't wait ⏳
On behalf of our #PVActionForce community, PVA Nat'l President Robert Thomas testified before @SVACGOP + @SVACDems on vacancies, delayed infrastructure projects, & how too few long-term care beds put #Veterans at risk.
Watch: https://t.co/lL0dIKXsQd.
When leaders act, heroes win 🏆
After a Senate hearing, we honored Senator @JerryMoran with our Mansfield Award for championing the Dole Act and working with our #PVActionForce to keep #PushingAccessForward for #Veterans.
Read about his leadership: https://t.co/CopqtUiHs5.
Chronic pain can be difficult to manage - but there are evidence-based, non-invasive options you can explore from the comfort of home.
This article from our partner @H_Wave outlines several at-home modalities for effective pain relief, including approaches that ⬇️
The brain remains one of science’s most complex frontiers. Georgia Tech is taking on that challenge with INNS — and Christopher Rozell will lead as its inaugural executive director.
https://t.co/PUNt5EGGcb #Neuroscience#AI#Research
Every step. Every swing. Every day.
Neurorehab is my life.
This is full-body, intent-driven rewiring: therapist-guided locomotor training + robotic arm swing with my @myomoinc MyoPro to activate my paralyzed arm from brachial plexus injury.
#NeuroplasticityInAction#SCIRecovery
Excited to join Georgia Tech’s Biomedical Engineering Ph.D. program! After an SCI ended my Air Force pilot training, I shifted to neuroplasticity research, proving recovery is possible. Now, I’m advancing neuromodulation to redefine SCI care and functional independence. #NeuroSci
🎉 Today marks a truly historic moment – not just for our company, but for the entire spinal cord injury (SCI) community.
After more than a decade of pioneering research and unwavering dedication, we have received FDA de novo classification and authorization to market the ARC-EX® System, the world's first non-invasive spinal cord stimulation system proven to improve strength and sensation after chronic SCI. 💫
Here are some key highlights of the ARC-EX System:
⭐️ 90% of clinical trial participants showed improved strength or function* in clinical trials
⭐️ Benefits seen up to 34 years post-injury* in clinical trials
⭐️ Named a @TIME Magazine Best Invention of 2024
For the first time ever, there is an approved therapy to improve hand strength and sensation for people with SCI. This recognition is particularly meaningful because it acknowledges more than just technological innovation – it validates the benefits of this therapy for the millions of people worldwide who dream of regaining movement and independence after SCI.
We thank the entire SCI Community for supporting us in our journey to develop and introduce this breakthrough technology. Together, we are not just developing devices; we are reshaping what is possible after spinal cord injury. 🚀
🔗 For more details, read our press release (link in comments).
*Moritz, Chet, et al. “Non-invasive spinal cord stimulation for arm and hand function in chronic tetraplegia: a safety and efficacy trial.” Nature Medicine. 2024.
#EmpoweringMovement #SCI #MedicalBreakthrough #Innovation
Note: The ARC-EX System is intended to deliver programmed, transcutaneous electrical spinal cord stimulation in conjunction with functional task practice in the clinic to improve hand sensation and strength in individuals between 18 and 75 years old that present with a chronic, non-progressive neurological deficit resulting from an incomplete spinal cord injury (C2-C8 inclusive). Please note that all other ONWARD Medical devices and therapies, including ARC-IM®, ARC-BCI®, and ARC Therapy™ with brain-computer interfaces (BCIs), are investigational and not commercially approved. Patient testimonials reflect individual experiences and outcomes, which may vary. Please review the full product label and clinical study data.
Ongoing @DeptVetAffairs staff shortages have led to...
🔴 Suspended care at 1 SCI/D unit
⚪️ #Veterans transferred 2 STATES away
🔵 1 NURSE for numerous cases
Join our #PVActionForce by #PushingAccessForward and urging reps to pass the CAREERS Act: https://t.co/ww0elS5jkj.